WHO Issues First Adult Type 1 Diabetes Guidelines
The World Health Organization (WHO) issued its first guidelines for diagnosing and managing type 1 diabetes in adults on 14 or 15 November 2026, ahead of World Diabetes Day. The guidance aims to improve access to essential care, particularly in low-resource, emergency and humanitarian settings.
Treatment and monitoring recommendations
The guidelines recommend multiple daily insulin injections, with doses adjusted according to blood glucose levels, and identify human insulin as an effective, affordable option. They strongly recommend regular blood glucose monitoring through finger-prick tests or continuous glucose monitoring (CGM); urine glucose testing may be used when blood glucose testing is unavailable. The guidance also addresses adults with type 1 diabetes being misdiagnosed as having type 2 diabetes, especially where diagnostic tools are limited.
Access and global burden
WHO said the guidelines support its goal of ensuring access to affordable insulin treatment and blood glucose self-monitoring for everyone with type 1 diabetes by 2030. Dr Søren Brostrøm, WHO Director of Noncommunicable Diseases and Mental Health, said many people still lack affordable, high-quality insulin more than a century after its discovery. An estimated 9.5 million people worldwide were living with type 1 diabetes in 2025, with 500,000 newly diagnosed that year. Globally, more than 40% of people with diabetes are estimated to be undiagnosed. The number of people living with diabetes has more than quadrupled since 1990; about 830 million people had diabetes in 2022, predominantly type 2.
Important Facts for Exams
- Autoimmune mechanism: Type 1 diabetes occurs when the immune system destroys insulin-producing pancreatic beta cells, causing insulin deficiency and elevated blood glucose.
- Adult-onset presentation: Adult-onset type 1 diabetes can develop over months with varied symptoms and is often initially mistaken for type 2 diabetes.
- Interstitial glucose: Continuous glucose monitors measure interstitial-fluid glucose rather than blood directly, so readings can lag behind changes in blood glucose.